Covered recipient · General Payments record
LIZAMARIE BACHIER-RODRIGUEZ
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$63,571.90
- Reported across 164 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,560.00 | 3 |
| Consulting Fee | $7,380.00 | 2 |
| Travel and Lodging | $3,045.30 | 7 |
| Food and Beverage | $1,058.37 | 40 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kite Pharma, Inc. | $17,778.74 | 17 |
| Gilead Sciences, Inc. | $2,440.00 | 1 |
| Genmab U.S., Inc. | $125.67 | 1 |
| ABBVIE INC. | $87.25 | 4 |
| Astellas Pharma US Inc | $84.79 | 3 |
| GlaxoSmithKline, LLC. | $62.15 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $57.61 | 2 |
| PFIZER INC. | $46.60 | 3 |
| Celgene Corporation | $45.92 | 2 |
| Janssen Biotech, Inc. | $42.76 | 2 |
| Karyopharm Therapeutics Inc. | $35.59 | 2 |
| SANOFI-AVENTIS U.S. LLC | $34.35 | 2 |
| Merck Sharp & Dohme Corporation | $30.87 | 1 |
| Alexion Pharmaceuticals, Inc. | $27.49 | 1 |
| BeiGene USA, Inc. | $21.52 | 1 |
| GENZYME CORPORATION | $19.83 | 1 |
| Acrotech Biopharma Inc. | $18.97 | 1 |
| SOBI, INC | $18.82 | 1 |
| Legend Biotech USA Inc. | $18.30 | 1 |
| Octapharma USA, Inc. | $17.74 | 1 |
| La Jolla Pharmaceutical Company | $15.63 | 1 |
| Genentech USA, Inc. | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.